Need Assistance?

US & Canada:
+
UK: +

Our Highlights

GMP Grade Efficient workshop for GMP production.
Optimal Prices Buying products on this site guarantees the best price!
Commercial Batches Independent GMP manufacturing suites that handle commercial batches
Prompt Delivery Warehouses in multiple cities to ensure timely delivery
Flexible Quantity Quantities available from milligrams to ton

CEF27, Epstein-Barr Virus BRLF-1 lytic 148-156

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

It is the 148-156 amino acid fragment of the BRLF1 protein. BRLF1 is a transcriptional activator that directly binds to GC-rich motif in the promoter of EBV lytic gene.

Category

Peptide Inhibitors

Catalog number

BAT-009350

CAS number

254110-79-7

Molecular Formula

C51H82N16O14

Molecular Weight

1143.32

CEF27, Epstein-Barr Virus BRLF-1 lytic 148-156

Specification

IUPAC Name

N2-[(2S,5S,8S,11S,14S,17S,20S,23S)-23,28-Diamino-17-(3-carbamimidamidopropyl)-1,4,7,10,13,16,19,22-octahydroxy-5,11-bis(4-hydroxybenzyl)-8-[(1R)-1-hydroxyethyl]-2-(hydroxymethyl)-28-imino-20-isoprop yl-14-methyl-3,6,9,12,15,18,21,27-octaazaoctacosa-3,6,9,12,15,18,21-heptaen-1-ylidene]-L-lysine

Synonyms

L-Lysine, L-arginyl-L-valyl-L-arginyl-L-alanyl-L-tyrosyl-L-threonyl-L-tyrosyl-L-seryl-; Arg-Val-Arg-Ala-Tyr-Thr-Tyr-Ser-Lys

Appearance

Solid powder

Purity

≥95%

Density

1.5±0.1 g/cm3

Boiling Point

1298.3±75.0°C at 760 mmHg

Sequence

RVRAYTYSK

Storage

Store at -20°C

Solubility

Soluble in Water

InChI

InChI=1S/C51H82N16O14/c1-26(2)39(66-42(73)33(53)9-7-21-58-50(54)55)47(78)61-34(11-8-22-59-51(56)57)43(74)60-27(3)41(72)63-37(24-30-14-18-32(71)19-15-30)45(76)67-40(28(4)69)48(79)64-36(23-29-12-16-31(70)17-13-29)44(75)65-38(25-68)46(77)62-35(49(80)81)10-5-6-20-52/h12-19,26-28,33-40,68-71H,5-11,20-25,52-53H2,1-4H3,(H,60,74)(H,61,78)(H,62,77)(H,63,72)(H,64,79)(H,65,75)(H,66,73)(H,67,76)(H,80,81)(H4,54,55,58)(H4,56,57,59)/t27-,28+,33-,34-,35-,36-,37-,38-,39-,40-/m0/s1

InChI Key

BPYLYQRPYWNUQU-DVEUAQCUSA-N